140 related articles for article (PubMed ID: 32487444)
1. Malignant insulinoma: 18F-DOPA and 68Ga-DOTATATE PET/CT and treatment with 177Lu-DOTATATE.
Erhamamcı S; Sager S; Asa S; Uslu L; Akgun E; Sonmezoglu K
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):383-386. PubMed ID: 32487444
[No Abstract] [Full Text] [Related]
2. Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome.
Novruzov F; Mehmetbeyli L; Aliyev JA; Abbasov B; Mehdi E
Clin Nucl Med; 2019 Jun; 44(6):e415-e417. PubMed ID: 30789400
[TBL] [Abstract][Full Text] [Related]
3. Is it possible NET-redifferentiation after chemotherapy?
Ergül N; Çermik TF; Dursun N
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):31-34. PubMed ID: 31122816
[TBL] [Abstract][Full Text] [Related]
4. Hepatopulmonary Shunt Reduction With 177Lu-DOTATATE Therapy.
Acar E; Çapa Kaya G; Durak H
Clin Nucl Med; 2016 Nov; 41(11):866-871. PubMed ID: 27607172
[TBL] [Abstract][Full Text] [Related]
5.
Tuzcu SA; Pekkolay Z; Kılınç F; Tuzcu AK
J Nucl Med Technol; 2017 Sep; 45(3):198-200. PubMed ID: 28798227
[TBL] [Abstract][Full Text] [Related]
6. Complete Resolution of Disease After Peptide Receptor Radionuclide Therapy in a Patient of Metastatic Insulinoma.
Verma P; Malhotra G; Dodamani MH; Lila AR; Asopa RV; Bandgar TR
Clin Nucl Med; 2022 Jan; 47(1):e77-e78. PubMed ID: 34284474
[TBL] [Abstract][Full Text] [Related]
7. Value of
Imperiale A; Boursier C; Sahakian N; Ouvrard E; Chevalier E; Sebag F; Addeo P; Taïeb D
J Nucl Med; 2022 Mar; 63(3):384-388. PubMed ID: 34272321
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Insulinoma Pancreatic Neuroendocrine Tumor Treated With 177Lu-DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy: A Suggested Protocol.
Makis W; McCann K; McEwan AJ
Clin Nucl Med; 2016 Jan; 41(1):53-4. PubMed ID: 26562579
[TBL] [Abstract][Full Text] [Related]
9. Tumor Heterogeneity Detected by 68Ga DOTATOC and 18F-FDG PET/CTs in One Malignant Insulinoma With Involvement of the Portal Splenic Confluence and Ovarian Metastases.
Bélissant Benesty O; Cassou-Mounat T; Vatier C; Talbot JN; Montravers F
Clin Nucl Med; 2016 Nov; 41(11):874-876. PubMed ID: 27607168
[TBL] [Abstract][Full Text] [Related]
10. Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.
Ong GS; Henley DE; Hurley D; Turner JH; Claringbold PG; Fegan PG
Eur J Endocrinol; 2010 May; 162(5):1001-8. PubMed ID: 20164213
[TBL] [Abstract][Full Text] [Related]
11. Resolution of Hyperreninemia, Secondary Hyperaldosteronism, and Hypokalemia With 177Lu-DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy in a Patient With Pancreatic Neuroendocrine Tumor.
Makis W; McCann K; Riauka TA; McEwan AJ
Clin Nucl Med; 2015 Nov; 40(11):880-4. PubMed ID: 26359564
[TBL] [Abstract][Full Text] [Related]
12. Ectopic insulinoma diagnosed by 68Ga-Exendin-4 PET/CT: A case report and review of literature.
Zhang X; Jia H; Li F; Fang C; Zhen J; He Q; Liu M
Medicine (Baltimore); 2021 Apr; 100(13):e25076. PubMed ID: 33787590
[TBL] [Abstract][Full Text] [Related]
13. Liver and bone metastases from small bowel neuroendocrine tumor respond to 177Lu-DOTATATE induction and maintenance therapies.
Makis W; McCann K; Buteau FA; McEwan AJ
Clin Nucl Med; 2015 Feb; 40(2):162-5. PubMed ID: 25243941
[TBL] [Abstract][Full Text] [Related]
14. Localization of Insulinoma Using 68Ga-DOTATATE PET/CT Scan.
Nockel P; Babic B; Millo C; Herscovitch P; Patel D; Nilubol N; Sadowski SM; Cochran C; Gorden P; Kebebew E
J Clin Endocrinol Metab; 2017 Jan; 102(1):195-199. PubMed ID: 27805844
[TBL] [Abstract][Full Text] [Related]
15. Repeated peptide receptor radiotherapy in multiple recurrences of a metastasized neuroendocrine tumor.
Brogsitter C; Zöphel K; Folprecht G; Eisenhofer G; Kotzerke J
Nuklearmedizin; 2017 Jun; 56(3):N19-N21. PubMed ID: 28358166
[No Abstract] [Full Text] [Related]
16. Application of Ga(68) -DOTA-exendin-4 PET/CT to localize an occult insulinoma.
Cuthbertson DJ; Banks M; Khoo B; Antwi K; Christ E; Campbell F; Raraty M; Wild D
Clin Endocrinol (Oxf); 2016 May; 84(5):789-91. PubMed ID: 26562613
[No Abstract] [Full Text] [Related]
17. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
[TBL] [Abstract][Full Text] [Related]
18. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
19. [Intermittent disturbances of perception during fasting in a 46-year-old female patient].
Ravens S; Scheit L
Internist (Berl); 2020 Sep; 61(9):964-968. PubMed ID: 32734334
[TBL] [Abstract][Full Text] [Related]
20. Gallbladder Uptake Mimicking Liver Metastasis on 177Lu-DOTATATE Posttherapy Scan Gallbladder Uptake on 177Lu-DOTATATE Scan.
Araz M; Baltacioglu MH; Saglam S; Ozguven MA; Kucuk NO
Clin Nucl Med; 2021 Mar; 46(3):e154-e155. PubMed ID: 33512839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
